Skip to Main Content

Paper Details

Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen.
J Invest Dermatol
34
2008

Datasets

Release 1.2